Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
ImmunityBio Inc (NASDAQ: IBRX) closed the day trading at $2.76 down -3.83%% from the previous closing price of $2.87. In other words, the price has decreased by -$3.83% from its previous closing price. On the day, 6.71 million shares were traded.
Ratios:
For a better understanding of IBRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.05 and its Current Ratio is at 2.22.
On March 06, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $8.
On January 10, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on January 10, 2025, with a $6 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 78.03.
Stock Price History:
Over the past 52 weeks, IBRX has reached a high of $7.63, while it has fallen to a 52-week low of $1.83. The 50-Day Moving Average of the stock is 3.39%, while the 200-Day Moving Average is calculated to be -17.52%.
Shares Statistics:
A total of 853.39M shares are outstanding, with a floating share count of 91.82M. Insiders hold about 89.60% of the company’s shares, while institutions hold 9.08% stake in the company.
